论文部分内容阅读
多年气管炎、哮喘病一次性根除国药“中华咳喘Ⅰ号”问世北京国际红十字会中医药研究院,是国家唯一担任气管炎、哮喘病研究与攻关的权威性科研机构,汇集了中外多位著名科研专家,多年来致力于呼吸道疾病最佳特效药的研发,在破译人类气管炎、哮喘病的研究上又获得重大突破,专家们采用呼吸生物学、免疫学的健康理论疗法,融入冬虫夏草、蛤蚧、人参、黄芪、葛根、浮海石等百余种高原名贵中草药进行组合试验,利用国外高科技低温萃取技术,终于成功研制出治疗气管炎、哮喘病的新一代“绿色国药”中华咳喘Ⅰ号“。该药能迅速修复受损呼吸道黏膜细胞,促进肺部正常功能细胞再生,恢复气管换气功能,提高肺部氧气供应量,咳、喘、憋病症消失,打破了”用药缓解,停药复发“这一难题,2009年在美国纽约召开的国际医药评比会上荣获”金奖“。国家保密配方,并通过国际药品”GMP“认证。该药的诞生受到全世界的关注。经日本现代药物研究院,法国药物实验室,英国呼吸道研究中心等多家国际权威机构数万例气管炎、哮喘病患者临床验证:对急慢性、老年性、过敏性、遗传性气管炎,支气管炎,哮喘,矽肺,尘肺,肺气肿,肺大泡、慢阻肺,肺心病,胸闷气短,咳嗽痰多等有特效(本药不含激素),
Years of bronchitis, asthma, a one-time eradication of Chinese medicine, ”Chinese cough I“ come out Beijing International Red Cross Research Institute of Chinese Medicine, is the only country as a bronchitis, asthma research and research authority of the research institutions, brought together Many famous Chinese and foreign scientific experts have devoted themselves to the research and development of the best effective drugs for respiratory diseases over the years and have made major breakthroughs in the study of deciphering the human bronchitis and asthma. The experts adopted the theories of respiratory biology and immunology, Into the Cordyceps sinensis, Gecko, ginseng, Astragalus, Pueraria, floating sea stone more than 100 kinds of plateau valuable Chinese herbal medicine combination test, the use of foreign high-tech low-temperature extraction technology, finally successfully developed a new generation of treatment of bronchitis, asthma, ”green medicine The Chinese medicine can quickly repair damaged respiratory mucosal cells, and promote normal lung regeneration of cells, restore tracheal ventilation function, improve lung oxygen supply, cough, asthma, suffocation symptoms disappear, Broke the “medication remission, withdrawal relapse ” this problem, in 2009 in New York, United States International Medical Competition won the “Gold Award.” State secrecy formula , And through the international drug “GMP ” certification. The birth of the drug by the world’s attention by the Japan Modern Drug Research Institute, the French Drug Laboratory, the British Respiratory Research Center and other international authorities tens of thousands of cases of bronchitis, Clinical validation of asthma patients: acute and chronic, senile, allergic, hereditary bronchitis, bronchitis, asthma, silicosis, pneumoconiosis, emphysema, bullae, COPD, pulmonary heart disease, chest tightness, shortness of breath, cough phlegm More and more effects (the drug does not contain hormones),